Seed VC · USA
Funding the future of life sciences by investing in companies enabling biotechnology, cell and gene therapies, vaccines, and regenerative medicine.
Business models
deeptech_ip, biotech_therapeutics, platform, hardware
Customer segments
Researchers, Biopharmaceutical companies, Clinical labs
Geography
US, Europe
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Dynamk Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Dynamk Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Dynamk Capital is one of them, and we'll tell you exactly where they sit in your top 100.